RE:A Cynic Might SayDomino55 wrote: - That "forces" are setting up to make the recent option handout look like a bargain at 32 cents.
A cynic might also say that these "forces" seem to have no limit on what they are prepared to do to make this late stage, multi P3 look as un-buyable as possible.
An optimist might say that as well ;)
The more "unbuyable, the more owners retain for themselves" As in..."this pie is crrap, you should avoid it altogether, it tastes really bad...I'll just suffer through eating myself, cuz I just hate to throw things out"
All as we progress
inexorably* toward interim Trial results, and Trial completion (PMX), and
35 person Trial start (DIMI - 6 weeks in Clinic and 6 weeks at home).
This is the
ONLY thing that matters in the case of P3 Companies (eventual Trial completion and FDA Ruliing). Paradigm assumes PMX has a 75% probability of approval. Mgt.s is telling us that the Tigris Trial is "
exceeding expectations". They only have to "confirm" Euphrates subset results. FDA Trial parameters are highly favourable (2:1, open label, Bayesisan, use of Euphrates data, etc.) Seto says DIMI approval is a "
when, not if" outcome.
*inexorably adverb -
in a way that is impossible to stop or prevent.